CSF3 and acute myeloid leukemia: Additionally, we showed that the injection of GCSF into the normal group or the AML (alone), CYT (alone), or in combination with AML significantly decreased the percentage of STs with apoptotic cells compared to the relevant groups without GCSF and CT only at 2 weeks post-treatment.